Clinical Trials Browser

Phase 2 × Multiple Myeloma × Protein Subunit Vaccines × Clear all

NCT00162500 2010-11-10

A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms